Trial · NCT03130959
Results by group300
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 300
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Safety Lead-In Participants With Dose Limiting Toxicities (DLTs) | Arm A1, Safety Lead-in | 0 | Number of participants | ||
| Number of Safety Lead-In Participants With Dose Limiting Toxicities (DLTs) | Arms A2-A5, Safety Lead-in | 0 | Number of participants | ||
| Number of Safety Lead-In Participants With Dose Limiting Toxicities (DLTs) | Arms B2-B5, Safety Lead-in | 0 | Number of participants | ||
| Number of Safety Lead-In Participants With Serious Adverse Events (SAEs) | Arm A1, Safety Lead-in | 7 | Number of participants | ||
| Number of Safety Lead-In Participants With Serious Adverse Events (SAEs) | Arms A2-A5, Safety Lead-in | 6 | Number of participants | ||
| Number of Safety Lead-In Participants With Serious Adverse Events (SAEs) | Arms B2-B5, Safety Lead-in | 8 | Number of participants | ||
| Number of Safety Lead-In Participants With Adverse Events (AEs) Leading to Discontinuation | Arm A1, Safety Lead-in | 3 | Participants | ||
| Number of Safety Lead-In Participants With Adverse Events (AEs) Leading to Discontinuation | Arms A2-A5, Safety Lead-in | 4 | Participants | ||
| Number of Safety Lead-In Participants With Adverse Events (AEs) Leading to Discontinuation | Arms B2-B5, Safety Lead-in | 2 | Participants | ||
| Overall Survival (OS), Cohort 1 Only | Arm A1 | 11.66 | 80% Confidence Interval 10.32 to 16.46 | months | |
| Overall Survival (OS), Cohort 1 Only | Arm B1 | 10.78 | 80% Confidence Interval 9.13 to 15.77 | months | |
| Progression-Free Survival (PFS), Cohorts 2-4 | Arm A2 | 1.74 | 80% Confidence Interval 1.35 to 2.73 | months | |
| Progression-Free Survival (PFS), Cohorts 2-4 | Arm B2 | 1.31 | 80% Confidence Interval 1.18 to 1.45 | months | |
| Progression-Free Survival (PFS), Cohorts 2-4 | Arm A3 | 1.38 | 80% Confidence Interval 1.22 to 1.38 | months | |
| Progression-Free Survival (PFS), Cohorts 2-4 | Arm B3 | 2.76 | 80% Confidence Interval 1.48 to 4.53 | months | |
| Progression-Free Survival (PFS), Cohorts 2-4 | Arm A4 | 1.41 | 80% Confidence Interval 1.41 to 2.60 | months | |
| Progression-Free Survival (PFS), Cohorts 2-4 | Arm B4 | 4.60 | 80% Confidence Interval 1.41 to 5.39 | months | |
| Progression-Free Survival (PFS), Cohort 5 Only | Arm A5 | 1.22 | 95% Confidence Interval 1.08 to 1.31 | months | |
| Progression-Free Survival (PFS), Cohort 5 Only | Arm B5 | 1.61 | 95% Confidence Interval 1.31 to 3.45 | months | |
| Progression-Free Survival (PFS), Cohort 1 Only | Arm A1 | 6.21 | 95% Confidence Interval 3.75 to 6.54 | Months |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03130959/results